Document is current
Any future updates will be listed below
-
Authors
Schrag, Matthew https://orcid.org/0000-0001-7048-0503
Mac Grory, Brian
Nackenoff, Alex
Eaton, James
Mistry, Eva
Kirshner, Howard
Yaghi, Shadi
Ellis, Christopher R.
- License Information
-
More Information
Article History
Received: 7 July 2020
Revised: 28 July 2020
Accepted: 30 July 2020
First Online: 7 August 2020
Compliance with Ethical Standards
:
: Matthew Schrag is funded by the NIH (NINDS 1R03NS111486, 1R21NS106510and NIA 1K76AG060001) and serves on the DSMB for the REVISION trial. Shadi Yaghi has received research funding from Medtronic. Christopher Ellis receives research funding and serves as a consultant for Medtronic Inc. He also serves as a consultant for Boston Scientific Inc., AtriCulture Inc., and Abbot Medical Inc.
: The OSCAAR study follows a cohort of 134 patients with CAA in the Vanderbilt Cerebral Microvascular Diseases Clinic and was approved by the Institutional Review Board, approval # 180287. VaLAAR follows a cohort of over 600 patients who have undergone LAAC at Vanderbilt University Medical Center and was approved by the Institutional Review Board, approval #150110. An additional cohort was included from Rhode Island Hospital/Brown University, IRB# 1313000.
